Literature DB >> 11772851

Signs and Symptoms of Psychotic Illness (SSPI): a rating scale.

Peter F Liddle1, Elton T C Ngan, Gary Duffield, King Kho, Anthony J Warren.   

Abstract

BACKGROUND: In the rating scales commonly used for assessing response to antipsychotic treatment, individual items embrace symptoms that apparently arise from distinguishable pathophysiological processes and might be expected to respond differently to treatment. AIMS: To test the reliability, sensitivity to change and factor structure of a new scale for the assessment of the Signs and Symptoms of Psychotic Illness (the SSPI).
METHOD: Interrater reliability was evaluated by determining the intraclass correlation for the ratings of 63 patients. Sensitivity to change was assessed in a longitudinal study of 33 patients. Factor structure was determined from scores for 155 patients.
RESULTS: The intraclass correlation was satisfactory for all individual items and excellent for the total score. Scores were sensitive to change. A change in Clinical Global Impression of one unit corresponded to an SSPI total score change of 31%. Factor analysis revealed five clusters of symptoms.
CONCLUSIONS: The SSPI provides a sensitive and reliable measure of the five major clusters of symptoms that occur commonly in psychotic illness.

Entities:  

Mesh:

Year:  2002        PMID: 11772851     DOI: 10.1192/bjp.180.1.45

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  35 in total

1.  Dissociable morphometric differences of the inferior parietal lobule in schizophrenia.

Authors:  Lena Palaniyappan; Peter F Liddle
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-28       Impact factor: 5.270

2.  Selective attention impairment in Schizophrenia: can it explain source monitoring failure?

Authors:  Abdelaziz Ferchiou; Franck Schürhoff; E Bulzacka; Marion Leboyer; Andreï Szöke
Journal:  J Nerv Ment Dis       Date:  2010-10       Impact factor: 2.254

3.  Aberrant cortical gyrification in schizophrenia: a surface-based morphometry study.

Authors:  Lena Palaniyappan; Peter F Liddle
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

Review 4.  Psychomotor slowing in schizophrenia.

Authors:  Manuel Morrens; Wouter Hulstijn; Bernard Sabbe
Journal:  Schizophr Bull       Date:  2006-11-08       Impact factor: 9.306

5.  Symptom changes in five dimensions of the Positive and Negative Syndrome Scale in refractory psychosis.

Authors:  Todd S Woodward; Kwanghee Jung; Geoffrey N Smith; Heungsun Hwang; Alasdair M Barr; Ric M Procyshyn; Sean W Flynn; Mark van der Gaag; William G Honer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-15       Impact factor: 5.270

6.  Hallucination- and speech-specific hypercoupling in frontotemporal auditory and language networks in schizophrenia using combined task-based fMRI data: An fBIRN study.

Authors:  Katie M Lavigne; Todd S Woodward
Journal:  Hum Brain Mapp       Date:  2017-12-21       Impact factor: 5.038

7.  Preserved subliminal processing and impaired conscious access in schizophrenia.

Authors:  Antoine Del Cul; Stanislas Dehaene; Marion Leboyer
Journal:  Arch Gen Psychiatry       Date:  2006-12

8.  Abnormal hemodynamics in schizophrenia during an auditory oddball task.

Authors:  Kent A Kiehl; Michael C Stevens; Kim Celone; Matthew Kurtz; John H Krystal
Journal:  Biol Psychiatry       Date:  2005-05-01       Impact factor: 13.382

9.  Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.

Authors:  Daniel Fulford; Rahel Pearson; Barbara K Stuart; Melissa Fisher; Daniel H Mathalon; Sophia Vinogradov; Rachel L Loewy
Journal:  Psychiatry Res       Date:  2014-08-01       Impact factor: 3.222

10.  Left-dominant temporal-frontal hypercoupling in schizophrenia patients with hallucinations during speech perception.

Authors:  Katie M Lavigne; Lucile A Rapin; Paul D Metzak; Jennifer C Whitman; Kwanghee Jung; Marion Dohen; Hélène Lœvenbruck; Todd S Woodward
Journal:  Schizophr Bull       Date:  2014-02-19       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.